(Q46273482)
Statements
1 reference
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. (English)
1 reference
1 reference
T Olsson
1 reference
M S Freedman
1 reference
A Bar-Or
1 reference
J Oger
1 reference
D Patry
1 reference
C Young
1 reference
D Li
1 reference
H-P Hartung
1 reference
M Krantz
1 reference
L Ferenczi
1 reference
T Verco
1 reference
5 October 2011
1 reference
1 reference
77
1 reference
16
1 reference
1551-1560
1 reference
Identifiers
1 reference
1 reference